This post, originally featured on the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center blog “Cancer Matters," applauds the launch...
Late last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
There has been a series of immunotherapy approvals since the end of last year, and following this trend, on...
The field of cancer immunotherapy broke new ground last week when the U.S. Food and Drug Administration (FDA) announced...
Just days before the start of multiple myeloma awareness month, which began Sunday, March 1, the U.S. Food and...
Yet more good news emanated from the U. S. Food and Drug Administration (FDA) last week when it announced...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
Last week, the U.S. Food and Drug Administration (FDA) announced the first-ever approval of a treatment for Waldenström macroglobulinemia,...
Cancer immunotherapy, which entered 2014 with the accolade of Science magazine’s Breakthrough of the Year for 2013, ended the...